Investing.com - Financial Markets Worldwide
NVDA gained a massive 197% since our AI first added it in November - is it time to sell? 🤔Read more

Philippines to get China-donated vaccines this month for troops, medical staff

Published 02/11/2021, 02:16 PM
Updated 02/11/2021, 02:20 PM
© Reuters.
AZN
-
NVAX
-
SVA
-
AZN
-
MRNA
-
22UAy
-

MANILA, Feb 11 (Reuters) - The Philippines is set to receive
600,000 doses this month of Sinovac Biotech 's SVA.O COVID-19
vaccine donated by China, a portion of which will be used to
inoculate military personnel, a senior government official said
on Thursday.
Presidential spokesman Harry Roque told a regular news
conference the Feb. 23 arrival of the vaccines is certain, but
they would not be administered without the approval of the Food
and Drug Administration (FDA).
So far, only shots developed by AstraZeneca (NASDAQ:AZN) AZN.L and the
vaccine of Pfizer PFE.N and BioNTech 22UAy.DE have been
approved for emergency use in the country.
Roque said regulators have allowed "compassionate use" of
10,000 doses of a vaccine developed by China's Sinopharm for
President Rodrigo Duterte's security detail.
Roque said 100,000 of the 600,000 Sinovac doses will be
given to soldiers and the rest for medical workers.
The Philippines aims to start its mass vaccination programme
using 117,000 doses of the Pfizer-BioNTech vaccine secured
through the COVAX international vaccine-sharing facility, which
are also due to be delivered this month.
The Philippines has negotiated supply agreements with
Moderna MRNA.O , Gamaleya, Janssen, Pfizer, AstraZeneca,
Sinovac, Novavax NVAX.O for 148 million doses of coronavirus
vaccines, the bulk of which are is expected to arrive in the
second and third quarters of this year.
It is aiming this year to inoculate 70 million adults, or
two-thirds of the country's 108 million people, to achieve herd
immunity.
The Philippines has recorded 541,000 infections, including
11,400 deaths.


Latest comments

Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.